Compare Ross Stores, Inc. (ROST) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Ross Stores, Inc. trades at $225.21 (market cap $71.96B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Ross Stores, Inc. is far larger — about 4× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.01%). Which is the better fit depends on your goals.
| ROST | ZBH | |
|---|---|---|
Market Cap | $71.96B | $18.05B |
Sector | Consumer Cyclical | Health |
52-Week High | $255.23 | $104.26 |
52-Week Low | $144.67 | $79.58 |
Enterprise Value | $72.41B | $25.11B |
Dividend Yield | 0.79% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $229.31, down 0.6% on the day, amid a bearish technical signal but strong fundamental performance. The company has consistently beaten earnings estimates, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast, and raised its full-year outlook. Revenue reached $21.13B in 2025, with net income of $2.09B and robust profitability metrics, including a 42.63% ROE. Analysts maintain a bullish consensus with a $271.33 price target, though technical indicators show near-term resistance.
The outlook for ROST is positive, driven by strong execution, expanding margins, and resilient consumer demand for value retail. Investment opportunities include continued earnings growth and potential upside to analyst targets. Key risks involve macroeconomic sensitivity, competitive pressures, and any deviation from its traffic growth trajectory. The stock's valuation at a P/E of 27.73 requires sustained performance to justify further gains.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
